Platelets an inflammatory force in transplantation

American Journal of Transplantation

Volumn 7, Issue 11, 2007, Pages 2447-2454

  Morrell, C N ^a   Sun, H ^b   Swaim, A M ^a   Baldwin III, W M ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Endothelial cell; Macro phages; T cells

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; COMPLEMENT; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; B LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOTHELIUM CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE ADHESION; VASCULAR DISEASE;

B-LYMPHOCYTES; BLOOD PLATELETS; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; HUMANS; INFLAMMATION; STEM CELLS; T-LYMPHOCYTES; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 35248815922     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01958.x     Document Type: Short Survey

References (56)

1. Denis MM, Tolley ND, Bunting M et al. Escaping the nuclear confines: Signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005 122 : 379 391.
2. Schwertz H, Tolley ND, Foulks JM et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006 203 : 2433 2440.
3. Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol 2005 238 : 1 9.
4. Langer H, May AE, Daub K et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006 98 : e2-e10.
5. Massberg S, Konrad I, Schurzinger K et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006 203 : 1221 1233.
6. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003 101 : 2661 2666.
7. Porter KA. Morphological aspects of renal homograft rejection. Br Med Bull 1965 21 : 171 175.
8. Oluwole S, Wang T, Fawwaz R et al. Use of indium-111-labeled cells in measurement of cellular dynamics of experimental cardiac allograft rejection. Transplantation 1981 31 : 51 55.
9. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990 49 : 85 91.
10. Qian Z, Wasowska BA, Behrens E et al. C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol 1999 155 : 1293 1302.
11. Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM, III. Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 2002 169 : 4620 4627.
12. Ota H, Fox-Talbot K, Hu W et al. Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation 2005 79 : 276 281.
13. Xu H, Zhang X, Mannon RB, Kirk AD. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest 2006 116 : 769 774.
14. Shrivastava S, McVey JH, Dorling A. The interface between coagulation and immunity. Am J Transplant 2007 7 : 499 506.
15. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004 113 : 1440 1446.
16. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005 31 : 217 233.
17. Padilla A, Moake JL, Bernardo A et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004 103 : 2150 2156.
18. Argenbright LW, Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited. J Clin Invest 1992 89 : 259 272.
19. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003 9 : 61 67.
20. Dole VS, Bergmeier W, Mitchell HA, Eichenberger SC, Wagner DD. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: Role of P-selectin. Blood 2005 106 : 2334 2339.
21. Laposata M, Krueger CM, Saffitz JE. Selective uptake of [3H]arachidonic acid into the dense tubular system of human platelets. Blood 1987 70 : 832 837.
22. Rocca B, Secchiero P, Ciabattoni G et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci USA 2002 99 : 7634 7639.
23. Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003 196 : 51 64.
24. Thomas DW, Rocha PN, Nataraj C et al. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J Immunol 2003 171 : 6389 6395.
25. Goulet JL, Griffiths RC, Ruiz P et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. J Immunol 2001 167 : 6631 6636.
26. Zhuge X, Arai H, Xu Y et al. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells. Biochem Biophys Res Commun 2006 351 : 865 871.
27. Flavahan NA. Balancing prostanoid activity in the human vascular system. Trends Pharmacol Sci 2007 28 : 106 110.
28. Bresalier RS, Sandler RS, Quan H et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005 352 : 1092 1102.
29. Farkouh ME, Greenberg JD, Jeger RV et al. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis 2007 66 : 764 770.
30. Weiss HJ, Witte LD, Kaplan KL et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979 54 : 1296 1319.
31. von Hundelshausen P, Weber KS, Huo Y et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001 103 : 1772 1777.
32. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000 96 : 4046 4054.
33. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003 59 : 277 287.
34. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967 13 : 269 288.
35. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998 102 : 136 144.
36. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000 95 : 1317 1323.
37. Hrachovinova I, Cambien B, Hafezi-Moghadam A et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003 9 : 1020 1025.
38. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988 263 : 18205 18212.
39. McCrae KR, Shattil SJ, Cines DB. Platelet activation induces increased Fc gamma receptor expression. J Immunol 1990 144 : 3920 3927.
40. Chen H, Marjan J, Cox AD, Devine DV. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets. J Immunol 1994 152 : 1332 1338.
41. Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004 103 : 2096 2104.
42. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005 201 : 871 879.
43. Ekdahl KN, Nilsson B. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets. J Immunol 1999 162 : 7426 7433.
44. Nilsson-Ekdahl K, Nilsson B. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1. Eur J Immunol 2001 31 : 1047 1054.
45. Danese S, de la Motte C, Sturm A et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003 124 : 1249 1264.
46. Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 2005 25 : 103 121.
47. Khandoga A, Hanschen M, Kessler JS, Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 2006 43 : 306 315.
48. Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: Recent advances on the role of platelets. J Hepatol 2007 46 : 719 726.
49. Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, Ratliff TL. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 2005 78 : 80 84.
50. Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 2002 99 : 3676 3682.
51. Katoh N, Soga F, Nara T et al. Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol 2006 146 : 354 361.
52. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: A potential bridge between injury and immune activation. Exp Hematol 2004 32 : 135 139.
53. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006 177 : 6780 6786.
54. Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007 204 : 1257 1265.
55. Hillebrands JL, Onuta G, Rozing J. Role of progenitor cells in transplant arteriosclerosis. Trends Cardiovasc Med 2005 15 : 1 8.
56. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007 100 : 967 978.